Xencor | Spese Operative

Created with Highcharts 10.1.0Chart context menu55.5M61.3M67.9M74.5M81.1M87.8M93.5M
2022Q32023Q32024Q3


Operating Expenses Cambiamento Data
AbbVie USD 16.59B 5.96B 2024-12
Alnylam Pharmaceuticals USD 698.32M 120.5M 2024-12
Amgen USD 6.78B 401M 2024-12
Arrowhead Research USD 163.91M 1.71M 2024-12
AstraZeneca USD 12.86B 2.06B 2024-12
Biogen USD 2.01B 13.3M 2024-12
Bristol-Myers Squibb USD 11.55B 1.84B 2024-12
Cytokinetics USD 155.97M 14.7M 2024-12
GlaxoSmithKline GBP 7.42B 402M 2024-12
J&J USD 18.63B 500M 2024-12
MacroGenics USD 56.52M 12.46M 2024-09
Merck USD 11.33B 1.4B 2024-12
Novartis USD 11.28B 1.73B 2024-12
Pfizer USD 18.17B 5.63B 2024-12
Regeneron Pharmaceuticals USD 2.8B 26.53B 2024-12
Roche Holding CHF 11.43B 1.48B 2024-12
Xencor USD 65.97M 7.02M 2024-12



Xencor Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.